Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paola Troisi
Observed names:
P Troisi,
P. Troisi
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0009-0009-4573-1732
Observed ORCID:
0009-0009-4573-1732
OpenAlex ID:
A5109732989
Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009–2023)
2025
·
Giovanni Maria Iannantuono
, Charalampos S. Floudas
, et al.
·
European Journal of Cancer
·
10
PDF
Pattern of disease recurrence and outcomes after progression of high-risk renal cell carcinoma (RCC) patients treated with adjuvant immunotherapy
2026
·
Chiara Ciccarese
, Denis Occhipinti
, et al.
·
Cancer Immunology Immunotherapy
·
4
PDF
Safety profile of BCG with or without immunotherapy in non–muscle-invasive bladder cancer (NMIBC): a systematic review and meta-analysis
2026
·
C. Ciccarese
, D. Occhipinti
, et al.
·
ESMO Open
·
1
A phase II study of encorafenib and cetuximab (EC) beyond progression in combination with FOLFIRI in BRAF V600E-mutated metastatic colorectal cancer (mCRC).
2025
·
Maria Alessandra Calegari
, Lisa Salvatore
, et al.
·
Journal of Clinical Oncology
·
1
PDF
500 Effects of Covid-19 Pandemics on Symptoms and Quality of Life in Patients Affected by Interstitial Cystitis/painful Bladder Syndrome (ic/pbs) and Irritable Bowel Syndrome (ibs)
2022
·
M Marturano
, G Campagna
, et al.
·
Continence
·
1
PDF
Emerging patterns of kidney cancer in young adults: where do we stand?
2026
·
Paola Troisi
, Denis Occhipinti
, et al.
·
Critical Reviews in Oncology/Hematology
Interobserver Agreement and Radiological–Pathological Concordance of CT Staging in Localized Colon Cancer
2026
·
Giovanni Trovato
, Maria Alessandra Calegari
, et al.
·
Clinical Colorectal Cancer
The ITALIC-RCC: A Randomized Trial on Clinical and Humoral Impact of Primary Tumor Ablation by Surgery or Radiotherapy in Metastatic Renal Cell Carcinoma Treated with Checkpoint Inhibitors
2026
·
Roberto Iacovelli
, Chiara Ciccarese
, et al.
·
European Urology Open Science
PDF
The ITALIC-RCC study: A randomized study of clinical and humoral impact of primary tumor ablation in metastatic renal cell carcinoma treated with immunotherapy.
2026
·
Paola Troisi
, Chiara Ciccarese
, et al.
·
Journal of Clinical Oncology
Pattern of disease recurrence and outcomes of localized high-risk renal cell carcinoma (RCC) patients treated with adjuvant (adj) immunotherapy: A single center experience.
2026
·
Denis Occhipinti
, Chiara Ciccarese
, et al.
·
Journal of Clinical Oncology
PDF
Impact of immunotherapy in patients with upper tract urothelial carcinoma: a meta-analysis of randomized trials
2026
·
Denis Occhipinti
, CHIARA CICCARESE
, et al.
·
SSRN Electronic Journal
PDF
Enhanced response to dabrafenib plus trametinib in a patient with BRAFV600E lung cancer harboring an RNF43 variant of unknown significance: a case report
2025
·
Ettore D’Argento
, Antonio Vitale
, et al.
·
Frontiers in Oncology
PDF
Correlation between multiorgan immune-related adverse events and clinical outcomes in patients with extensive-stage small cell lung cancer (ES-SCLC) treated with chemo-immunotherapy.
2024
·
Federico Monaca
, Martin Igor Gomez-Randulfe Rodriguez
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
13
Citation count:
17
H-index:
2
I10-index:
1
Year
Topic
Type